CHININUM SULFURICUM-INJEEL LIQ (12D,30D,200D/1.1ML) DIN 02058057
Health Canada record
| Active ingredient(s) | QUININE SULFATE 12 D |
|---|---|
| Dosage form | Liquid |
| Route | Oral |
| Schedule | HOMEOPATHIC |
| Class | Human |
| ATC | |
| Original market date | 31-Dec-1993 |
| Current status date | 05-Mar-1997 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing QUININE SULFATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02311216 | PRO-QUININE - 200 | PRO DOC LIMITEE | Capsule | QUININE SULFATE 200 MG | Marketed |
| 02311224 | PRO-QUININE - 300 | PRO DOC LIMITEE | Capsule | QUININE SULFATE 300 MG | Marketed |
| 00021016 | TEVA-QUININE | TEVA CANADA LIMITED | Capsule | QUININE SULFATE 300 MG | Marketed |
| 00021008 | TEVA-QUININE | TEVA CANADA LIMITED | Capsule | QUININE SULFATE 200 MG | Marketed |
| 02254522 | APO-QUININE | APOTEX INC | Capsule | QUININE SULFATE 300 MG | Dormant |
| 02254514 | APO-QUININE | APOTEX INC | Capsule | QUININE SULFATE 200 MG | Dormant |
| 00671363 | CHININUM SULF GLOBULE 4CH-30CH | BOIRON LABORATOIRES | Tablet | QUININE SULFATE 4 CH | Cancelled Post Market |
| 00677868 | CHININUM SULF GOUTTE 4CH-30CH | BOIRON LABORATOIRES | Drops | QUININE SULFATE 4 CH | Cancelled Post Market |
| 00855324 | CHININUM SULF GRANULES 3DH | HOMEOCAN INC. | Tablet | QUININE SULFATE 3 DH | Cancelled Post Market |
| 02233746 | CHININUM SULFURICUM | SEROYAL INTERNATIONAL INC. | Globules; Pellet; Granules; Liquid; Tablet; Drops | QUININE SULFATE 3 X | Cancelled Post Market |
| 02234409 | CHININUM SULFURICUM | DOLISOS CANADA INC. | Globules; Granules; Liquid | QUININE SULFATE 3 X | Cancelled Post Market |
| 00667609 | CHININUM SULFURICUM GOUTTE 4CH-30CH | DOLISOS LABORATOIRES S.A. | Drops | QUININE SULFATE 3 CH | Cancelled Post Market |
| 00698393 | CHININUM SULFURICUM GRANULE 3DH - 30CH | DOLISOS LABORATOIRES S.A. | Tablet | QUININE SULFATE 3 DH | Cancelled Post Market |
| 02077639 | HOMEOPATHIC MEDICINE (S NO.550) DPS 30C | TOTAL HEALTH CENTRE | Drops | QUININE SULFATE 30 C | Cancelled Post Market |
| 02445190 | JAMP QUININE | JAMP PHARMA CORPORATION | Capsule | QUININE SULFATE 200 MG | Dormant |
| 02445204 | JAMP QUININE | JAMP PHARMA CORPORATION | Capsule | QUININE SULFATE 300 MG | Dormant |
| 00695432 | QUININE - ODAN | ODAN LABORATORIESLTD | Tablet | QUININE SULFATE 300 MG | Dormant |
| 00695440 | QUININE - ODAN | ODAN LABORATORIESLTD | Capsule | QUININE SULFATE 200 MG | Dormant |
| 00695459 | QUININE - ODAN | ODAN LABORATORIESLTD | Capsule | QUININE SULFATE 300 MG | Dormant |
| 02241118 | QUININE SULFATE | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Capsule | QUININE SULFATE 200 MG | Cancelled Pre Market |
| 02241117 | QUININE SULFATE | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Capsule | QUININE SULFATE 300 MG | Cancelled Pre Market |
| 00178993 | QUININE SULFATE CAP 200MG | STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. | Capsule | QUININE SULFATE 200 MG | Cancelled Post Market |
| 00022837 | QUININE SULFATE CAP 200MG | PARKE-DAVIS DIVISION, WARNER-LAMBERT CANADA INC. | Capsule | QUININE SULFATE 200 MG | Cancelled Post Market |
| 00179000 | QUININE SULFATE CAP 300MG | STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. | Capsule | QUININE SULFATE 300 MG | Cancelled Post Market |
| 00022845 | QUININE SULFATE CAP 300MG | PARKE-DAVIS DIVISION, WARNER-LAMBERT CANADA INC. | Capsule | QUININE SULFATE 300 MG | Cancelled Post Market |
| 00093742 | QUININE SULFATE CAPSULES 200MG | D.C. LABS LIMITED | Capsule | QUININE SULFATE 200 MG | Cancelled Post Market |
| 00093750 | QUININE SULFATE CAPSULES 300MG | D.C. LABS LIMITED | Capsule | QUININE SULFATE 300 MG | Cancelled Post Market |
International API supply for QUININE SULFATE
1 valid EDQM Certificates of Suitability from 1 holders. 2 active FDA Drug Master Files.
Request a quote for CHININUM SULFURICUM-INJEEL LIQ (12D,30D,200D/1.1ML)